Cayman Pharma s.r.o.

Cayman Pharma is Europe’s most reliable and versatile source for Prostaglandin Active Pharmaceutical Ingredients (APIs). We own and practice a patented route to the prostaglandin core structure that was developed over many years of research in our headquarters near Prague. Our GMP processes are inspected and approved by both the European authorities and the FDA. From fertility, eye care, glaucoma, hypertension, and all of the other applications for these remarkable compounds — Cayman Pharma has the validated GMP routes and the regulatory approvals needed to help get your product to market.
Cayman Pharma is also helping make research possible by supplying scientists worldwide with biochemical tools in research disciplines such as: CANCER, METABOLIC DISORDERS, NEUROSCIENCES, APOPTOSIS, OXIDATIVE INJURY, EPIGENETICS, ENDOCRINOLOGY, and many more.
In addition, Cayman offers 4000+ high quality biochemicals manufactured by our parent company Cayman Chemical.

Specialties : 

Status: 

Operating

Industries: 

Employee Count Range: 

51-200

Company type: 

Public Company

Founded year: 

2001

Share this page